Disorders of Carnitine Biosynthesis Defects in carnitine biosynthesis can lead to a range of metabolic disorders, often with severe clinical implications
As of June 2025, the branded version of liraglutide, Saxenda, generated $165 million in annual sales alone, and the market for GLP-1s could be set to hit over $126 billion in sales by 2029
al fin y al cabo, el objetivo es divertirse, no perseguir prdidas ni forzar resultados
Introduction Diarrhea is one of the most common gastrointestinal side effects of GLP1 medications
Patients on these medications should have appropriate monitoring if using berberine
Of course, up until the last 100 years and still in some parts of the world, diseases like scurvy, rickets, beriberi, and pellagra, which are caused by frank deficiency of nutrients like vitamin C or B vitamins, etc., were still significant causes of death and disability in many parts of the world